Skyhawk, Announces

Skyhawk Announces Australia's Therapeutic Goods Administration Has Determined SKY-0515 for Huntington's Disease Meets Eligibility Criteria for Registration via the Provisional Approval Pathway

Veröffentlicht: 17.03.2026 um 22:59 Uhr, prnewswire.co.uk

Skyhawk Therapeutics Massachusetts

View original content:https://www.prnewswire.co.uk/news-releases/skyhawk-announces-australias-therapeutic-goods-administration-has-determined-sky-0515-for-huntingtons-disease-meets-eligibility-criteria-for-registration-via-the-provisional-approval-pathway-302701180.html

en | boerse | 68751051 |